Coluracetam
Research-chemical, Nootropic
A nootropic drug of the racetam class, originally developed to treat Alzheimer's disease, it is currently being investigated as a treatment for major depressive disorder and generalised anxiety disorder. The drug has some indications that it may be a modulator of the AMPA receptor. Reports indicate that there is limited recreational value.
Chart shows bounded mass ranges in mg. See the table for all doses.
Light
Common
Strong
Insufflated
2-5mg
5-10mg
10mg+
Oral
3-5mg
5-10mg
10-20mg+
Sublingual
2-5mg
5-10mg
10mg+
Onset
Insufflated
1m to 5m
Oral
15m to 30m
Sublingual
5m to 10m